Citation Impact
Citing Papers
Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE /NF ‐KB /JNK signaling pathway in aging mouse model
2014 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
2023
Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study
2017
Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease
2010
Oxidative stress, aging, and diseases
2018 Standout
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
2010
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Reactive oxygen species: from health to disease
2012 Standout
Antioxidants as potential therapeutics for neuropsychiatric disorders
2012
Asenapine increases nitric oxide release and protects porcine coronary artery endothelial cells against peroxidation
2014
Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke
2014
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology
2012
Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review
2021
Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development
2010
Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment
2011
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Brain-derived neurotrophic factor: findings in schizophrenia
2011
Free radicals, antioxidant defense systems, and schizophrenia
2013
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
2016
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
The Influence of Exercise on Cognitive Abilities
2012 Standout
Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging
2013
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Translational Findings on Brain-Derived Neurotrophic Factor and Anxiety: Contributions from Basic Research to Clinical Practice
2013 Standout
Oxidative stress in schizophrenia - focusing on the main markers.
2011
Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect
2016 Standout
Redox Probing for Chemical Information of Oxidative Stress
2016
α7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
2013
Works of Da Chun Chen being referenced
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia
2011
Plasma total antioxidant status and cognitive impairments in schizophrenia
2012
The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients
2009
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
2009
Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia
2011
Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia
2014
Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology
2015
Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes
2009
Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population
2009
The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients
2010
Association of the manganese superoxide dismutase gene Ala–9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients
2010
The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase
2004
Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics
2008
Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms
2011
Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls
2012
Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics
2009
Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
2012